Thank you for an excellent discussion regarding patient and disease selection.
During our exchange, Dr. Baylis brought up the point of financial resources being expended for the benefit of a few women and couples with mutated mtDNA.
The authors of the Perspective piece raise the concern that, “…enterprising reproductive medicine practitioners could seek to offer MRTs as conception aids to older women, which raises questions about the appropriate dissemination of a new reproductive technology beyond its envisioned disease-specific applications.”
Let’s think beyond treating rare diseases in a handful of patients. Let’s find additional meaningful and innovative uses for the technology.